Surviving Older Patients Show Preserved Cellular and Humoral Immunological Memory Several Months After SARS-CoV-2 Infection
Gerontology Journal
Fecha de publicación: 12 de julio de 2021
Autores: Alejandra García-Torre, MSc, Eva Bueno-García, MSc, Rocío López-Martínez, MSc, Beatriz Rioseras, PhD, Marco Antonio Moro-García, PhD, Sara Alonso-Alvarez, MD, Alba Lluna-González, RN, Alejandra Sousa-Fernández, RN, Marta Fernández-Gudin, RN, Laura Campos-Riopedre, RN, Corina Castro-del Cueto, RN, Ana Belén Pérez-Fernández, RN, Ana Alonso-Rodríguez, RN, Carla Menéndez-Peña, RN, Lara Menéndez-Peña, RN, Noelia García-Arnaldo, RN, Estefanía Feito-Díaz, RN, Adriana Fernández-Lorences, RN, Agustín Fraile-Manzano, MD, Carolina Fernández-Iglesias, MD, José Arturo Rivera, MD, Carmen Pérez-Fonseca, MD, Estibaliz Urdiales-Ruano, MD, María Debán-Fernández, MD, Hugo Mendes-Moreira, MD, Pablo Herrero-Puente, MD, Rebeca Alonso-Arias, PhD
DOI: https://doi.org/10.1093/gerona/glab206
Background: Understanding how older people respond to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical if we are to confront the coronavirus disease 2019 (COVID-19) pandemic and establish effective vaccination strategies. Immunosenescence reduces the ability to respond to neoantigens and may compromise the life of infected individuals.
